Calbiotech Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Calbiotech's estimated annual revenue is currently $9.5M per year.(i)
  • Calbiotech's estimated revenue per employee is $251,000

Employee Data

  • Calbiotech has 38 Employees.(i)
  • Calbiotech grew their employee count by 3% last year.

Calbiotech's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Scientific DirectorReveal Email/Phone
3
lab tech.Reveal Email/Phone
4
In TrainingReveal Email/Phone
5
ERP System AdministratorReveal Email/Phone
6
Assistant ELISA SupervisorReveal Email/Phone
7
ELISA supervisorReveal Email/Phone
8
Research ScientistReveal Email/Phone
9
Customer Service AssistantReveal Email/Phone
10
Business DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is Calbiotech?

Calbiotech is a worldwide leader in immunoassay development and manufacturing. With over 30 years of experience, the Calbiotech team has established itself as a leader in the industry, offering over 200 products distributed to over 50 countries. Our investments in automation and state-of-the-art technologies help ensure our customers receive high-quality, stable, flexible, automation-ready, and cost effective products and services. Calbiotech's Custom Development team is ready to take your innovation from Pipeline to Productionâ„¢. We have custom developed hundreds of coated microplates, reagents, buffers and other components for pharmaceutical companies, universities and research centers in the U.S. and around the world.

keywords:N/A

N/A

Total Funding

38

Number of Employees

$9.5M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.8M383%N/A
#2
$8.8M38-7%N/A
#3
$3.5M395%N/A
#4
$7.3M4018%N/A
#5
$7.3M405%N/A